Rhode Island Senate Bill S0099

Rhode Island 2023 Regular Session

• Introduced: 2/1/23
• Refer: 2/1/23

Caption

Wholesale Prescription Drug Importation Program

Impact

If enacted, S0099 will introduce a framework through which the state can procure prescription drugs at potentially lower prices due to importation from Canada, known for offering more competitive pricing for many medications. This program will designate a state agency to license as a drug wholesaler or contract with existing wholesalers, ultimately encouraging collaboration with Canadian drug suppliers. The program's focus on creating a structured importation method aims to streamline the process while maintaining safety and adherence to federal regulations.

Summary

S0099, also known as the Wholesale Prescription Drug Importation Program, is a legislative initiative aimed at providing cost savings on prescription drugs for Rhode Island consumers. The program is designed to allow wholesale importation of prescription drugs from Canada, contingent upon federal approval from the U.S. Department of Health and Human Services. It seeks to ensure that only safe and effective drugs, which meet the standards set forth by the FDA, are imported. The program emphasizes creating significant savings for consumers by importing drugs that are expected to generate such benefits.

Contention

Debate surrounding S0099 may arise regarding concerns about the safety and efficacy of imported drugs, alongside the logistics of establishing a sustainable importation program. Proponents argue that significant cost savings for consumers and a robust oversight mechanism can be achieved, while critics might raise concerns about reliance on foreign suppliers and the complexities of navigating international drug regulations. The bill also entails responsibilities for annual reporting by the overseeing agency, providing transparency and accountability regarding the program's execution and outcomes.